Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to $188000.0.

  • Q32 Bio's Non Operating Income fell 8457.75% to $188000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 9236.01%. This contributed to the annual value of $20.0 million for FY2024, which is 48713.73% up from last year.
  • Latest data reveals that Q32 Bio reported Non Operating Income of $188000.0 as of Q3 2025, which was down 8457.75% from -$318000.0 recorded in Q2 2025.
  • Q32 Bio's 5-year Non Operating Income high stood at $131.3 million for Q1 2022, and its period low was -$6.2 million during Q3 2023.
  • Over the past 5 years, Q32 Bio's median Non Operating Income value was $474000.0 (recorded in 2022), while the average stood at $7.9 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 34537631.58% in 2022, then crashed by 58605.2% in 2023.
  • Quarter analysis of 5 years shows Q32 Bio's Non Operating Income stood at $42000.0 in 2021, then skyrocketed by 3364.29% to $1.5 million in 2022, then tumbled by 169.07% to -$1.0 million in 2023, then surged by 135.62% to $358000.0 in 2024, then crashed by 47.49% to $188000.0 in 2025.
  • Its Non Operating Income was $188000.0 in Q3 2025, compared to -$318000.0 in Q2 2025 and $1.2 million in Q1 2025.